Pharmaceutical excipients are the substances other than the active pharmaceutical ingredient (API) that have been appropriately evaluated for safety as well as efficacy and are intentionally included in a drug delivery system. This agents are added in formulations to aid the manufacturing process, to protect, support or enhance stability, or for bioavailability or patient acceptability. The excipients are inert and simple to active and complex substances that can be difficult to characterize. It plays vital role in drug delivery within the body. It assist in product identification, and enhance any attribute of the overall safety.
The factors responsible for market growth are rising adoption of orphan drugs and increasing demand for functionality excipients. Hence, bone growth stimulator market has been seeing tremendous growth from the past few decades. Likewise, rapid advancements in nanotechnology will fuel growth of the market in upcoming years. Nevertheless, cost and time-intensive drug development process and increasing regulatory stringency are the major restraining factor that could hamper the growth of the market.
The COVID 19 outbreak causes ill impact on many industries and also had significant impact on the healthcare market. As the rise in COVID 19 cases, for prevention purpose government has announced lockdown in many countries which lead to disturbance in manufacturing and supply of raw materials in various countries. But for COVID 19 treatment demand for drugs such as Remdesivir and hydroxychloroquine has increased which will boosts market growth. During this pandemic process of drug development and manufacturing of raw materials has increased. Hence, COVID 19 negligible impacted the growth of the overall market in 2020.
North America Pharmaceutical Excipients Market Segmental Overview
The study analyses North America Pharmaceutical Excipients Market based on product, functionality, formulations and country.
By the various products the pharmaceutical excipients market is bifurcated into organic and inorganic chemicals. Organic chemicals are further sub-segmented into carbohydrates and petrochemicals. Inorganic chemicals are sub-segmented into Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites and Metallic Oxides. The organic chemicals segment is expected to account for the largest share of the market in 2020. The factors boosting market growth rise in demand for organic chemicals as excipients in many formulations. It has wide application conventional dosage forms as well as novel drug delivery systems hence, it will boosts market growth.
Based on the functionality the pharmaceutical excipients market is classified into fillers & diluents, binders, suspending & viscosity agents, flavoring agents & sweeteners, coating agents, colorants, disintegrants, lubricants & glidants, preservatives, emulsifying agents, and other functionalities. The fillers and diluents segment is expected to grow at the highest rate during the forecast period 2021-2027. Fillers & diluents plays vital role in increase the volume of the material to enable easier processing of the ingredients and diluents acts as a disintegrants in dispersible and orally disintegrating tablet.
Depending to the formulations the pharmaceutical excipients market is classified into oral, topical, parenteral, and other formulations. The oral formulations segment dominated the market in 2020 and is expected to maintain its dominance during the forecast period 2021-2027 owing to, the effectiveness and wide usage of various oral formulations results in increase in demand for oral formulations. Also the availability of the wide range of oral formulations such as tablets, capsules, syrups will fuel market growth in upcoming years.
Country wise, the study is comprised of the key countries such as the Unites States (US), Mexico and Canada. The US held the largest market share of North America pharmaceutical excipients market and is likely to dominate the market over the forecast period 2021-2027. The country’s such as US, Mexico and Canada, surge rise in demand for market due to increasing expenditure to healthcare sector.
The major key players of market includes Ashland Global Holdings (US), BASF SE (Germany), DuPont (US), Roquette Feres (France), Evonik Industries AG (Germany), Associated British Foods (UK), Archer Daniels Midland Company (US), Lubrizol Corporation (US), and Croda International (UK), Innophous Holdings (US), Kerry Group (Ireland), WACKER Chemie AG (Germany), Colorcon (US), DFE Pharma (Germany), JRS Pharma (Germany), and Air Liquide (France).
July 2020: Colorcon launched the Acryl-EZE II film coating line which extends the pH range covered by its enteric coatings.
October 2020: Evonik launched the EUDRATEC Fasteric releases, an advanced oral drug delivery technology that provides enteric protection ollowed by rapid, homogeneous release for effective targeting of the upper small intestine.
December 2018: Roquette (France) signed an agreement with Thermo Fisher. Roquette signed an agreement with ThermoFisher Scientific (US), which gives Thermo the right to distribute Roquette’s products in the US and Canada. This will provide further market access to Roquette.
May 2019, Ashland announced the launch of Aquarius Nutra TF, which provides titanium oxide-based coating to tablets in the European market.
The study analyses North America pharmaceutical excipients market product, functionality, formulations and country. Pharmaceutical excipients are substances other than the active pharmaceutical ingredient (API) that have been appropriately evaluated for safety and are intentionally included in a drug delivery system. Various pharmaceutical excipients included in this report are fillers & diluents, binders, suspending & viscosity agents, flavoring agents & sweeteners, coating agents, colorants, disintegrants, lubricants & glidants, preservatives, emulsifying agents, and other functionalities. The primary growth factors behind the market growth are growth of the pharmaceuticals market backed by functional excipients and surge in the generics market. Increasing uptake of biopharmaceuticals will drive market growth in upcoming years. The established safety and efficacy of excipients in dosage forms is expected to impede market growth over the forecast period 2021-2027. Country wise study comprises countries like US, Mexico and Canada. The US held the largest market share of North America pharmaceutical excipients market and is likely to dominate the market over the estimated time frame due to advancement in technologies.
Why to buy this report: